These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6827537)

  • 1. Synthesis and antihypertensive activity of stereoisomers of 4-piperidyl-1,3-dihydro-2-oxo-2H-benzimidazoles. Enhanced potencies of (+) isomers.
    Kasuya Y; Shigenobu K; Hashikami M; Karashima N; Obase H; Takai H; Teranishi M; Karasawa A; Kubo K
    J Med Chem; 1983 Feb; 26(2):208-13. PubMed ID: 6827537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotensive action of a new benzimidazolinone derivative, threo-1-(2-hydroxy-2-(3,4,5-trimethoxyphenyl)-1-methylethyl)-4-(1,3-dihydro-2H-benzimidazol-2-one-1-yl)piperidine (KF-4942): prazosin-like mode of action.
    Karasawa A; Shuto K; Kubo K; Kasuya Y; Hashikami M; Shigenobu K
    Arch Int Pharmacodyn Ther; 1983 Feb; 261(2):278-90. PubMed ID: 6132590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester.
    Muto K; Kuroda T; Kawato H; Karasawa A; Kubo K; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1662-5. PubMed ID: 3219137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiropiperidines. I. Synthesis of 1'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one derivatives and evaluation of their antihypertensive activity.
    Takai H; Obase H; Teranishi M; Karasawa A; Kubo K; Shuto K; Kasuya Y; Hashikami M; Karashima N; Shigenobu K
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1129-39. PubMed ID: 4028295
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues.
    Horino H; Mimura T; Kagechika K; Ohta M; Kubo H; Kitagawa M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):602-9. PubMed ID: 9579035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomers of diastereomeric cis-N-[1-(2-hydroxy-2-phenylethyl)- 3-methyl-4-piperidyl]-N-phenylpropanamides: synthesis, X-ray analysis, and biological activities.
    Brine GA; Stark PA; Liu Y; Carroll FI; Singh P; Xu H; Rothman RB
    J Med Chem; 1995 Apr; 38(9):1547-57. PubMed ID: 7739013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octahydropyrazino[2',3':3,4]pyrido[1,2-a]indoles. A new class of potent antihypertensive agents.
    Jirkovsky I; Santroch G; Baudy R; Oshiro G
    J Med Chem; 1987 Feb; 30(2):388-94. PubMed ID: 3806618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,4'-piperidine]s and 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,3'-pyrrolidine]s: novel antihypertensive agents.
    Davis L; Agnew MN; Effland RC; Klein JT; Kitzen JM; Schwenkler MA
    J Med Chem; 1983 Oct; 26(10):1505-10. PubMed ID: 6620309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl 5-(4,6-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate dihydrochloride (NIP-101).
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2370-6. PubMed ID: 1446357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypotensive properties of benzodioxane derivatives structurally related to R 28935. Comparison of activity with some receptor affinities.
    Timmermans PB; Slothorst-Grisdijk FP; van Kemenade JE; Schoop AM; Batink HD; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1982 Feb; 255(2):321-34. PubMed ID: 6280629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Touzeau F; Arrault A; Guillaumet G; Scalbert E; Pfeiffer B; Rettori MC; Renard P; Mérour JY
    J Med Chem; 2003 May; 46(10):1962-79. PubMed ID: 12723959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A benzodioxanhydroxyethylpiperidine derivative with an acute central hypotensive action, different from that of clonidine. A comparison with neuroleptic agents.
    Van Zwieten PA
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):104-18. PubMed ID: 1156040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1- and 3-(1-substituted 4-piperidinyl)-1,2,3,4-tetrahydro-2-oxoquinazolines as potential antihypertensive agents.
    Takai H; Obase H; Nakamizo N; Teranishi M; Kubo K; Shuto K; Kasuya Y; Shigenobu K; Hashikami M; Karashima N
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1116-28. PubMed ID: 4028294
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication.
    Wikel JH; Paget CJ; DeLong DC; Nelson JD; Wu CY; Paschal JW; Dinner A; Templeton RJ; Chaney MO; Jones ND; Chamberlin JW
    J Med Chem; 1980 Apr; 23(4):368-72. PubMed ID: 6247489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
    Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
    J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
    Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substances with potential cardiovascular action. 2-acylaminobenzimidazoles with hypotensive activity].
    Bellasio E; Campi A; Trani A; Baldoli E; Caravaggi AM; Nathansohn G
    Farmaco Sci; 1973 Feb; 28(2):164-82. PubMed ID: 4692791
    [No Abstract]   [Full Text] [Related]  

  • 18. A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay.
    Smith ED; Ariane Vinson N; Zhong D; Berrang BD; Catanzaro JL; Thomas JB; Navarro HA; Gilmour BP; Deschamps J; Carroll FI
    Bioorg Med Chem; 2008 Jan; 16(2):822-9. PubMed ID: 17976996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive activity of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-ET]-4-piperidyl)-2-benzimidazolinone (R 28935).
    Wellens D; Snoeckx L; De Reese R; Kruger R; Van de Water A; Woutens L; Reneman RS
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):119-32. PubMed ID: 1156041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antihypertensive activity of substituted trans-4-amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols.
    Evans JM; Fake CS; Hamilton TC; Poyser RH; Watts EA
    J Med Chem; 1983 Nov; 26(11):1582-9. PubMed ID: 6631915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.